Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03492554 · ClinicalTrials.gov registry record · NA
Electrocardiogram Clinical Validation Study
A NA study of Atrial Fibrillation, sponsored by Apple.
- Completed
- Registry status
- NA
- Development phase
- 602
- Enrollment target
- 5
- Study locations
NCT03492554 is a NA study of Atrial Fibrillation that has completed, run by Apple. The registered enrollment target is 602 participants, below the 2,994-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (80% lower). The trial reports 5 study locations across 3 states.
The verdict
NCT03492554, a NA study of Atrial Fibrillation, has completed, sponsored by Apple.
- COMPLETED
- Registry status
- NA
- Development phase
- 602 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of the study is to confirm the software's ability to create a Lead-1 electrocardiogram (ECG) that is clinically equivalent to a reference device. Also, to confirm a rhythm classification algorithm and its ability to detect and classify heart rhythms into two categories (Sinus Rhythm or Atrial Fibrillation) using a single Lead ECG.
Conditions Studied
Interventions
- OTHER 1-Lead ECG
- DEVICE 12-Lead ECG
Study Locations (5)
Florida
- QPS - Miami
- BioClinicia- Orlando - Orlando
- BioClinica- The Villages - The Villages
Kansas
- IQVIA - Overland Park
Minnesota
- Health East - Saint Paul
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 602 participants |
| Start Date | 2018-03-12 |
| Est. Completion | 2018-05-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03492554
The ClinicalTrials.gov registry entry for NCT03492554 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 602 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,994-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (80% lower). The listed sponsor is Apple, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 2 interventions - of which 1-Lead ECG is the first listed.
NCT03492554 reports 5 study locations spanning 3 distinct geographic areas - top geographies include Florida, Kansas, Minnesota.
Frequently Asked Questions
What is clinical trial NCT03492554 about?
NCT03492554 is a clinical study titled "Electrocardiogram Clinical Validation Study". The purpose of the study is to confirm the software's ability to create a Lead-1 electrocardiogram (ECG) that is clinically equivalent to a reference device. Also, to confirm a rhythm classification algorithm and its ability to detect and classify heart rhythms into two categories (Sinus Rhythm or A...
What is the current status of trial NCT03492554?
This trial is currently completed. It is a NA study. The enrollment target is 602 participants. The study started on 2018-03-12. Estimated completion is 2018-05-14.
What conditions does trial NCT03492554 study?
This clinical trial studies the following conditions: Atrial Fibrillation.
What interventions are being tested in trial NCT03492554?
The interventions under investigation include: 1-Lead ECG (OTHER), 12-Lead ECG (DEVICE).
Who is sponsoring clinical trial NCT03492554?
This trial is sponsored by Apple, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03492554 being conducted?
This trial has 5 study locations across Florida, Kansas, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Renal Denervation + PVI vs PVI Alone for Persistent AF
RECRUITING · NA
-
Pericardiotomy in Cardiac Surgery
RECRUITING · NA
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
RECRUITING · NA
-
The CONFORM Pivotal Trial
RECRUITING · NA
-
Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study
RECRUITING · NA
-
The Fourth Left Atrial Appendage Occlusion Study
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.